SCHEMBL2851877

SCHEMBL2851877

C/C=C(/C(=O)O)c1ccccc1COc1ccc(Br)cn1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 2/20 0.45
FFAR1 O14842 2/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 3/20 0.38
FOLH1 Q04609 1/20 0.38
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
CD274 Q9NZQ7 3/20 0.36
HTT P42858 1/20 0.36
OPRL1 P41146 1/20 0.35
USP2 O75604 1/20 0.35
PDCD1 Q15116 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CXCR2 P25025 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8338900 1.00 GABRA5 (0.45) GABRA5FFAR1ALDH1A1KDM4EFOLH1
SCHEMBL8338895 0.90 GABRA5 (0.42) GABRA5FFAR1ALDH1A1KDM4EFOLH1
SCHEMBL2851880 0.90 GABRA5 (0.42) GABRA5FFAR1ALDH1A1KDM4EFOLH1
SCHEMBL2851872 0.90 GABRA5 (0.42) GABRA5FFAR1ALDH1A1KDM4EFOLH1
SCHEMBL203005 0.83 GABRA5 (0.42) GABRA5FFAR1ALDH1A1KDM4EFOLH1
SCHEMBL8724339 0.82 GABRA5 (0.40) GABRA5FFAR1ALDH1A1FOLH1SMN1; SMN2
SCHEMBL203004 0.81 SMN1; SMN2 (0.39) GABRA5KDM4ELMNASMN1; SMN2TP53
SCHEMBL31289594 0.81 SMN1; SMN2 (0.39) GABRA5KDM4ELMNASMN1; SMN2TP53
SCHEMBL29358985 0.81 SMN1; SMN2 (0.39) GABRA5KDM4ELMNASMN1; SMN2TP53
SCHEMBL203006 0.80 KDM4E (0.40) GABRA5FFAR1ALDH1A1KDM4EFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043600-B2 Microbiocidal compounds SYNGENTA CROP PROTECTION AG (CH) 2024-07-23 US disclosed
US-12012399-B2 Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2024-06-18 US disclosed
US-20240041028-A1 DELIVERY SYSTEM FOR PLANT PROTECTION OMYA INTERNATIONAL AG (CH) 2024-02-08 US disclosed
US-11882834-B2 Microbiocidal thiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2024-01-30 US disclosed
EP-4271185-A1 DELIVERY SYSTEM FOR PLANT PROTECTION Omya International AG (CH) 2023-11-08 EP disclosed
US-11744246-B2 Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide SYNGENTA PARTICIPATIONS AG (CH) 2023-09-05 US disclosed
EP-3717479-B1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2023-07-05 EP disclosed
EP-3941898-B1 FUNGICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-06-07 EP disclosed
EP-3244732-B1 USE OF SURFACE-REACTED CALCIUM CARBONATE AS CARRIER FOR AGROCHEMICAL COMPOUNDS OMYA INT AG (CH) 2023-05-03 EP disclosed
US-11629138-B2 Microbiocidal picolinamide derivatives SYNGENTA PARTICIPATIONS AG (CH) 2023-04-18 US disclosed
US-7001903-B2 Synergistic insecticidal mixtures BAYER AKTIENGESELLSCHAFT (DE) 2006-02-21 US disclosed
US-20050187215-A1 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-08-25 US disclosed
US-6893651-B1 Synergistic combination of cyclic ketoenol with agonists or antagonists of nicotinic acetylcholine receptors; protecting plants BAYER AKTIENGESELLSCHAFT (DE) 2005-05-17 US disclosed
US-6846777-B2 Synergistic biocidal composition THOR GMBH (DE) 2005-01-25 US disclosed
US-20040127520-A1 Synergistic insecticidal mixtures DOW AGROSCIENCES LLC 2004-07-01 US disclosed
US-6686387-B2 SPINOSYNS AND AGONISTS OR ANTAGONISTS OF NICOTINIC ACETYLCHOLINE RECEPTORS; PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2004-02-03 US disclosed
US-20030199490-A1 Synergistic biocidal composition THOR GMBH (DE) 2003-10-23 US disclosed
US-20030092641-A1 Synergistic insecticidal mixtures DOW AGROSCIENCES LLC 2003-05-15 US disclosed
US-6444667-B1 OF SPINOSYNS AND AGONISTS OR ANTAGONISTS OF NICOTINIC ACETYLCHOLINE RECEPTORS FOR PROTECTING PLANTS BAYER AKTIENGESELLSCHAFT (DE) 2002-09-03 US disclosed
US-5466693-A FOE USE IN THE CULTIVATION OF RICE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092641-A1 Synergistic insecticidal mixtures CHRM3, ACHE, CHRM2 GABRA5 370/4885FFAR1 942/4885ALDH1A1 4569/4885
US-12043600-B2 Microbiocidal compounds MPO, MSR1, PRF1 GABRA5 2323/4885FFAR1 492/4885ALDH1A1 500/4885
US-20040127520-A1 Synergistic insecticidal mixtures CHRM3, ACHE, CHRM2 GABRA5 370/4885FFAR1 942/4885ALDH1A1 4569/4885
US-11882834-B2 Microbiocidal thiazole derivatives MSR1, TLR1, IFNG GABRA5 2564/4885FFAR1 648/4885ALDH1A1 392/4885
US-12012399-B2 Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives TLR1, TLR5, IDO1 GABRA5 3613/4885FFAR1 1006/4885ALDH1A1 312/4885
US-20050187215-A1 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors CHRNG, CHRM3, CHRNE GABRA5 201/4885FFAR1 132/4885ALDH1A1 2646/4885
US-11629138-B2 Microbiocidal picolinamide derivatives PRF1, CASP1, FPR1 GABRA5 2332/4885FFAR1 169/4885ALDH1A1 1067/4885
US-11744246-B2 Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide PHF20, FUCA1, ZP1 GABRA5 3848/4885FFAR1 783/4885ALDH1A1 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.